VAS, Quality of Life, Nasal Provocation Test
The global estimation of improvement on VAS did not show any difference after treatment in any of the studies. The Quality of Life (QoL) was unchanged in ILIT after SCIT- 10 000 but improved in the placebo group and not in the active group in ILIT de novo- 3000. The Nasal Provocation Test (NPT) did not change in any of the studies. (See Figure E3 and supplementary information.)